Thirty years of primary immunodeficiencies in Turkey

Annals of the New York Academy of Sciences

Volumn 1238, Issue 1, 2011, Pages 15-23

  Sanal, Ozden ^a   Tezcan, Ilhan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Autosomal recessive diseases; Major immunodeficiency groups; Primary immunodeficiency disease; Rare diseases; Turkey

Indexed keywords

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CONSANGUINEOUS MARRIAGE; CONSANGUINITY; HUMAN; IMMUNOPATHOLOGY; INCIDENCE; PHENOTYPE; PREVALENCE; PRIMARY IMMUNODEFICIENCY; RARE DISEASE; RHEUMATIC FEVER; SUBACUTE SCLEROSING PANENCEPHALITIS; TURKEY (REPUBLIC);

EID: 82555165280     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06242.x     Document Type: Article

References (89)

1. Bousfiha, A. et al. 2010. Primary immunodeficiencies of protective immunity to primary infections. Clin. Immunol. 135: 204-209.
2. Pessach, I., J. Walter & L.D. Notarangelo. 2009. Recent advances in primary immunodeficiencies: identification of novel genetic defects and unanticipated phenotypes. Pediatr. Res. 65: 3R-12R.
3. International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies, Notarangelo L.D. et al. 2009. Primary immunodeficiencies: 2009 update. J. Allergy Clin. Immunol. 124: 1161-1178.
4. Stiehm, E.R. 1993. New and old immunodeficiencies. Pediatr. Res. 33: S2-S8.
5. Casanova, J.L. & L. Abel. 2007. Primary immunodeficiencies: a field in its infancy. Science 317: 617-619.
6. Alper, O.M. et al. 2004. Consanguineous marriages in the province of Antalya, Turkey. Ann. Genet. 47: 129-138.
7. Fudenberg, H. et al. 1971. Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics 47: 927-946.
8. Berkel, A.I. et al. 1976. Thymic dysplasia with normal immunoglobulins (the Nezelof syndrome). (A case report.) Turk. J. Pediatr. 18: 45-52.
9. Berkel, A.I. et al. 1977. A case of selective Clq deficiency. Turk. J. Pediatr. 19: 101-108.
10. Berkel, A.I. et al. 1978. Reduced cellular immunity with normal immunoglobulins and defective antibody production in twins. Pediatr. Res. 12: 63.
11. Yegin, O. et al. 1978. Malabsorption, megaloblastic anemia and X-linked immunodeficiency with hyper IgM. Turk. J. Pediatr. 20: 116-123.
12. Berkel, A.I. & F. Ersoy. 1978. Histocompatibility (HLA) factors in ataxia telangiectasia. Boll. Ist. Sieroter. Milan. 57: 26-29.
13. Berkel, A.I. et al. 1981. Clinical symptomatology in patients with selective complete Clq deficiency. Pediatr. Res. 15: 1212.
14. Ersoy, F. et al. 1982. Thymic humoral factor (THF) therapy in a patient with Di-George syndrome. Turk. J. Pediatr. 23: 115-120.
15. Berkel, A.I. et al. 1977. Transfer factor therapy in ataxia-telangiectasia. Clin. Exp. Immunol. 29: 376-384.
16. Buckley, R.H. et al. 1976. Heterogeneity of lymphocyte sub-populations in severe combined immunodeficiency. Evidence against a stem cell defect. J. Clin. Invest. 58: 130-136.
17. Sanal, O. & R.H. Buckley. 1978. Antibody dependent cellular cytotoxicity in primary immunodeficiency diseases and with normal leukocyte subpopulations. Importance of the type of target. J. Clin. Invest. 61: 1-10.
18. Berkel, A.I. et al. 1973. Serum alpha fetoprotein in childhood. Turk. J. Pediatr. 15: 171-178.
19. Berkel, A.I. & O. Kiran. 1974. Immunological studies in children with xeroderma pigmentosum. Turk. J. Pediatr. 16: 43-52.
20. Meriç, N. & A.I. Berkel. 1979. Cellular immunity in children with acute rheumatic fever and rheumatic carditis. Pediatr. Res. 13: 16-20.
21. Berkel, A.I. et al. 1979. Epstein-Barr virus related antibody patterns in ataxia-telangiectasia. Clin. Exp. Immunol. 35: 196-201.
22. Yalçin, B. et al. 1980. Haematological and immunological features of Behçet's disease. Haematologica 65: 390-394.
23. Müftüoǧlu, A.U. & B. Yalçin. 1980. Lack of correlation between skin reactivity and T lymphocytes and monocytes in Hodgkin's disease. Acta Haematol. 63: 286-288.
24. Yegin, O. et al. 1983. Defective lymphocyte locomotion in Chediak-Higashi syndrome. Am. J. Dis. Child. 137: 771-773.
25. Aysun, S. et al. 1983. HLA antigens in subacute sclerosing panencephalitis. Arch. Neurol. 40: 38-39.
26. Aysun, S. et al. 1983. Cell-mediated immunity, serum and lymphocyte zinc levels in Hodgkin's disease. Prog. Clin. Biol. Res. 129: 255-260.
27. Aysun, S. 1984. Cell mediated immunity in patients with subacute sclerosing panencephalitis. Brain Dev. 6: 391-396.
28. Masucci, G. 1984. Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients. J. Clin. Immunol. 4: 369-382.
29. Sanal, O. et al. 1985. Spontaneous cytotoxicity against measles virus infected and K562 cells in normal subjects and subacute sclerosing panencephalitis. Boll. Ist. Sieroter. Milan. 64: 400-403.
30. Ozer, N.K. et al. 1985. Studies on lymphocyte cell surface in ataxia-telangiectasia. Clin. Exp. Immunol. 61: 118-124.
31. Sanal, O. et al. 1992. Complement component deficiencies and infection: C5, C8 and C3 deficiencies in three families. Eur. J. Pediatr. 151: 676-679.
32. Yavuzyilmaz, E. et al. 1993. Neutrophil chemotaxis and periodontal status in Down's syndrome patients. J. Nihon Univ. Sch. Dent. 35: 91-95.
33. Ozbaş-Gerçeker, F. et al. 2003. The effect of mannose-binding protein gene polymorphisms in recurrent respiratory system infections in children and lung tuberculosis. Turk. J. Pediatr. 45: 95-98.
34. Gatti, R.A. et al. 1988. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 336: 577-580.
35. Sanal, O. et al. 1990. Further mapping of an ataxia-telangiectasia locus to the chromosome 11q23 region. Am. J. Hum. Genet. 47: 860-866.
36. Sanal, O. et al. 1992. Ataxia-telangiectasia: linkage analysis of chromosome 11q22-23 markers in Turkish families. FASEB J. 6: 2848-2852.
37. Sanal O. et al. 1993. Clinical variants of ataxia-telangiectasia. In Ataxia Telengiectasia, Nato ASI Series. R.A. Gatti & R.B. Painter, Eds.: Vol H: 77. Springer Verlag. Berlin.
38. Savitsky, K. et al. 1995. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753.
39. Sanal, O. et al. 2004. Defective anti-polysaccharide antibody response in patients with ataxia-telangiectasia. Turk. J. Pediatr. 46: 208-213.
40. Mesci, L. et al. 2011. H2AX gene does not have a modifier effect on ataxia-telangiectasia phenotype. Int. J. Immunogenet. 38: 209-213.
41. Devgan, S.S. et al. 2011. Homozygous deficiency of ubiquitin-ligase ring-finger protein RNF168 mimics the radiosensitivity syndrome of ataxia-telangiectasia. Cell Death Differ. 18: 1500-1506.
42. Demiral, K. 2007. Clinical and Laboratory Features and Follow-up of 362 Ataxia Telangiectasia Patients. Thesis for General Pediatrics. Immunology Division, Hacettepe University Children's Hospital, Ankara, Turkey.
43. Tezcan, I. et al. 1999. Successful bone marrow transplantation in a case of Griscelli disease which presented in accelerated phase with neurological involvement. Bone Marrow Transplant. 24: 931-933.
44. Caǧdaş, D. et al. Two SCID cases with Cernunnos-XLF deficiency successfully treated by hematopoietic stem cell transplantation. Pediatr. Transplant. doi:.
45. Ozgür, T.T. et al. 2008. Hematopoietic stem cell transplantation in a CD3 gamma-deficient infant with inflammatory bowel disease. Pediatr. Transplant. 12: 910-913.
46. Aytekin, C. et al. 2008. An unconditioned bone marrow transplantation in a child with purine nucleoside phosphorylase deficiency and its unique complication. Pediatr. Transplant. 12: 479-482.
47. Sanal, O. et al. 2002. Griscelli disease: genotype-phenotype correlation in an array of clinical heterogeneity. J. Clin. Immunol. 22: 237-243.
48. Sanal, O. et al. 1993. Griscelli's syndrome: clinical features of three siblings. Turk. J. Pediatr. 35: 115-119.
49. Pastural, E. et al. 1997. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat. Genet. 16: 289-292.
50. Sanal, O. et al. 2000. An allelic variant of Griscelli disease: presentation with severe hypotonia, mental-motor retardation, and hypopigmentation consistent with Elejalde syndrome (neuroectodermal melanolysosomal disorder). J. Neurol. 247: 570-572.
51. Ménasché, G. et al. 2003. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J. Clin. Invest. 112: 450-456.
52. Revy, P. et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575.
53. Kutukculer, N. et al. 2003. Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. J. Pediatr. 142: 194-196.
54. Quartier, P. et al. 2004. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. Clin. Immunol. 10: 22-29.
55. Péron, S. et al. 2008. Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination. J. Exp. Med. 205: 2465-2472.
56. Sanal, O. et al. 1996. Low expression of T-cell receptor-CD3 complex: a case with a clinical presentation resembling humoral immunodeficiency. Turk. J. Pediatr. 38: 81-84.
57. Recio, M.J. et al. 2007. Differential biological role of CD3 chains revealed by human immunodeficiencies. J. Immunol. 178: 2556-2564.
58. Minegishi, Y. et al. 1999. Mutations in Ig alpha (CD79a) result in a complete block in B-cell development. J. Clin. Invest. 104: 1115-1121.
59. Wang, Y. 2002. Novel Igalpha (CD79a) gene mutation in a Turkish patient with B cell-deficient agammaglobulinemia. Am. J. Med. Genet. 108: 333-336.
60. Verhagen C.E. et al. 2000. Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells. J. Exp. Med. 192: 517-528.
61. Ottenhoff, T.H. et al. 2002. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat. Genet. 32: 97-105.
62. Lichtenauer-Kaligis, E.G. et al. 2003. Severe mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta1 deficient patients and evidence for the existence of partial IL-12 receptor beta1 deficiency. Eur. J. Immunol. 33: 59-69.
63. Camcioglu, Y. et al. 2004. HHV-8-associated Kaposi sarcoma in a child with IFNgammaR1 deficiency. J. Pediatr. 144: 519-523.
64. Sanal, O. et al. 2006. Presentation of interleukin-12/-23 receptor beta1 deficiency with various clinical symptoms of salmonella infections. J. Clin. Immunol. 26: 1-6.
65. Sanal, O. et al. 2007. A case of interleukin-12 receptor beta-1 deficiency with recurrent leishmaniasis. Pediatr. Infect. Dis. J. 26: 366-368.
66. de Beaucoudrey, L. et al. 2008. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J. Exp. Med. 205: 1543-1550.
67. Al Khatib, S. et al. 2009. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J. Allergy Clin. Immunol. 124: 342-348.
68. de Beaucoudrey, L. et al. 2010. Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 89: 381-402.
69. Moshous, D. et al. 2001. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105: 177-186.
70. Buck, D. et al. 2006. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124: 287-299.
71. van der Burg, M. et al. 2009. A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining. J. Clin. Invest. 119: 91-98.
72. van Zelm, M.C. et al. 2006. An antibody-deficiency syndrome due to mutations in the CD19 gene. N. Engl. J. Med. 354: 1901-1912.
73. Pasvolsky, R. et al. 2007. LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets. J. Exp. Med. 204: 1571-1582.
74. Kuijpers, T.W. et al. 2007. Natural history and early diagnosis of LAD-1/variant syndrome. Blood 109: 3529-3535.
75. Mory, A. et al. 2008. Kindlin-3: a new gene involved in the pathogenesis of LAD-III. Blood 112: 2591.
76. Kuijpers, T.W. et al. 2009 LAD-1/variant syndrome is caused by mutations in FERMT3. Blood 113: 4740-4746.
77. Svensson, L. et al. 2009. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat. Med. 15: 306-312.
78. Minegishi, Y. et al. 2006. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25: 745-755.
79. von Bernuth, H.J.L. et al. 2008. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321: 691-696.
80. Engelhardt, K.R. et al. 2009. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J. Allergy Clin. Immunol. 124: 1289-1302.
81. Yuksek, M. et al. 2010. Primary immune deficiency disease awareness among a group of Turkish physicians. Turk. J. Pediatr. 52: 372-377.
82. Modell, F., D. Puente & V. Modell. 2009. From genotype to phenotype. Further studies measuring the impact of a Physician Education and Public Awareness Campaign on early diagnosis and management of primary immunodeficiencies. Immunol. Res. 44: 132-149.
83. Sanal, O. et al. DOCK8 immunodeficiency syndrome: a newly recognized disease with diverse manifestations. Submitted.
84. Tanir, G. et al. 2006. Complete deficiency of the IL-12 receptor beta1 chain: three unrelated Turkish children with unusual clinical features. Eur. J. Pediatr. 165: 415-417.
85. Boisson-Dupuis, S. et al. 2011. IL-12Rβ1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey. PLoS One 6: e18524.
86. Ozbek, N. et al. 2005. Interleukin-12 receptor beta 1 chain deficiency in a child with disseminated tuberculosis. Clin. Infect. Dis. 40: e55-58.
87. Köker, M.Y. et al. 2009. Four different NCF2 mutations in six families from Turkey and an overview of NCF2 gene mutations. Eur. J. Clin. Invest. 39: 942-951.
88. Köker, M.Y. et al. 2009. Six different CYBA mutations including three novel mutations in ten families from Turkey, resulting in autosomal recessive chronic granulomatous disease. Eur. J. Clin. Invest. 39: 311-319.
89. Buckley, R.H. 2004. The multiple causes of human SCID. J. Clin. Invest. 114: 1409-1411.